JP7319761B2 - 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物 - Google Patents

非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物 Download PDF

Info

Publication number
JP7319761B2
JP7319761B2 JP2017533218A JP2017533218A JP7319761B2 JP 7319761 B2 JP7319761 B2 JP 7319761B2 JP 2017533218 A JP2017533218 A JP 2017533218A JP 2017533218 A JP2017533218 A JP 2017533218A JP 7319761 B2 JP7319761 B2 JP 7319761B2
Authority
JP
Japan
Prior art keywords
grape
product
seed
mammal
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017533218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017538758A5 (enExample
JP2017538758A (ja
Inventor
トーリー・ジェイムズ・アーヴィク
ヒョンスーク・キム
ウォレス・エイチ・ヨコヤマ
スコット・アール・フォースバーグ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Agriculture USDA
Original Assignee
US Department of Agriculture USDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Agriculture USDA filed Critical US Department of Agriculture USDA
Publication of JP2017538758A publication Critical patent/JP2017538758A/ja
Publication of JP2017538758A5 publication Critical patent/JP2017538758A5/ja
Priority to JP2021017048A priority Critical patent/JP7461901B2/ja
Application granted granted Critical
Publication of JP7319761B2 publication Critical patent/JP7319761B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2017533218A 2014-12-20 2015-12-18 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物 Active JP7319761B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021017048A JP7461901B2 (ja) 2014-12-20 2021-02-05 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094963P 2014-12-20 2014-12-20
US62/094,963 2014-12-20
PCT/US2015/066585 WO2016100774A1 (en) 2014-12-20 2015-12-18 Grape products for nonalcoholic fatty liver disease and other uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021017048A Division JP7461901B2 (ja) 2014-12-20 2021-02-05 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Publications (3)

Publication Number Publication Date
JP2017538758A JP2017538758A (ja) 2017-12-28
JP2017538758A5 JP2017538758A5 (enExample) 2019-01-31
JP7319761B2 true JP7319761B2 (ja) 2023-08-02

Family

ID=56127659

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017533218A Active JP7319761B2 (ja) 2014-12-20 2015-12-18 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物
JP2021017048A Active JP7461901B2 (ja) 2014-12-20 2021-02-05 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021017048A Active JP7461901B2 (ja) 2014-12-20 2021-02-05 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Country Status (8)

Country Link
US (4) US10130671B2 (enExample)
EP (1) EP3233101A4 (enExample)
JP (2) JP7319761B2 (enExample)
KR (2) KR20240059654A (enExample)
AU (1) AU2015364473B2 (enExample)
CA (1) CA2971716A1 (enExample)
IL (1) IL252992B (enExample)
WO (1) WO2016100774A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021075551A (ja) * 2014-12-20 2021-05-20 ソノマシューティカルズ・エルエルシー 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020138557A1 (ko) * 2018-12-28 2020-07-02 경상대학교병원 지방간 예방 또는 치료용 약학적 조성물 및 건강기능식품
JP2021073987A (ja) * 2019-11-12 2021-05-20 禅インターナショナル株式会社 栄養組成物
CN111826437B (zh) * 2020-07-24 2023-09-29 中南大学湘雅二医院 检测cyp46a1基因表达的产品在制备诊断非酒精性脂肪性肝病工具中的应用
JP2023545515A (ja) 2020-10-16 2023-10-30 ソノマシューティカルズ・エルエルシー 農産物搾りかすを含む食品組成物とその製造方法
KR102573089B1 (ko) 2020-11-27 2023-09-01 한양대학교 산학협력단 비 알콜성 지방간 치료제에 대한 감수성 예측을 위한 바이오 마커 및 이의 용도
US20240100001A1 (en) * 2021-02-01 2024-03-28 Aardvark Therapeutics Inc. Denatonium salt for use in preventing, preventing progression and treating fatty liver diseases
TR2023010537A2 (tr) * 2023-08-28 2023-11-21 Bursa Uludag Ueniversitesi Buzağılarda Oksidatif Stresin Azaltılması İçin Üzüm Çekirdeği Ekstraktı Kullanımı

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692837A5 (it) 1997-07-02 2002-11-29 Lisapharma Spa Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p
CA2711475A1 (en) * 2008-01-10 2009-07-16 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
CN102300578A (zh) * 2008-12-01 2011-12-28 延寿有限责任公司 用于改变健康、安康和寿命的方法和组合物
US8609156B2 (en) 2009-10-05 2013-12-17 Protanza Corporation Compositions and methods of treatment that include plant extracts
JP2012187050A (ja) * 2011-03-10 2012-10-04 Manns Wine Co Ltd ワイン風飲料及びこれを含有する飲食品
NZ701607A (en) * 2012-04-30 2017-04-28 Sonomaceuticals Llc Therapeutic use of chardonnay seed products
US20150258032A1 (en) * 2014-03-17 2015-09-17 Kenneth Dale Lightburn Compositions of Antioxidants and Oil for an antioxidant paste or supplement or liquid or frozen product
KR20240059654A (ko) * 2014-12-20 2024-05-07 소노마슈티컬스, 엘엘씨 비알콜성 지방간 질환용 및 다른 용도의 포도 생산물

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Ｃｈａｒｒａｄｉ Ｋ ｅｔ ａｌ．，Ｐｒｏｔｅｃｔｉｖｅ ｅｆｆｅｃｔ ｏｆ ｇｒａｐｅ ｓｅｅｄ ａｎｄ ｓｋｉｎ ｅｘｔｒａｃｔ ａｇａｉｎｓｔ ｈｉｇｈ－ｆａｔ ｄｉｅｔ－ｉｎｄｕｃｅｄ ｌｉｖｅｒ ｓｔｅａｔｏｓｉｓ ａｎｄ ｚｉｎｃ ｄｅｐｌｅｔｉｏｎ ｉｎ ｒａｔ，Ｄｉｇｅｓｔｉｖｅ Ｄｉｓｅａｓｅｓ ａｎｄ Ｓｃｉｅｎｃｅｓ，２０１４年 ４月，Ｖｏｌ．５９， Ｎｏ．８，ｐ．１７６８－１７７８，ｄｏｉ： １０．１００７／ｓ１０６２０－０１４－３１２８－０
Ｃｈｏｉ ＳＫ ｅｔ ａｌ．，Ｓｕｐｐｒｅｓｓｉｏｎ ｏｆ ｏｘｉｄａｔｉｖｅ ｓｔｒｅｓｓ ｂｙ ｇｒａｐｅ ｓｅｅｄ ｓｕｐｐｌｅｍｅｎｔａｔｉｏｎ ｉｎ ｒａｔｓ，Ｎｕｔｒｉｔｉｏｎ Ｒｅｓｅａｒｃｈ ａｎｄ Ｐｒａｃｔｉｃｅ，２０１２年，Ｖｏｌ．６， Ｎｏ．１，ｐ．３－８，ｄｏｉ： １０．４１６２／ｎｒｐ．２０１２．６．１．３
Ｈｗａｎｇ ＩＫ ｅｔ ａｌ．，Ｅｆｆｅｃｔｓ ｏｆ ｇｒａｐｅ ｓｅｅｄ ｅｘｔｒａｃｔ ａｎｄ ｉｔｓ ｅｔｈｙｌａｃｅｔａｔｅ／ｅｔｈａｎｏｌ ｆｒａｃｔｉｏｎ ｏｎ ｂｌｏｏｄ ｇｌｕｃｏｓｅ ｌｅｖｅｌｓ ｉｎ ａ ｍｏｄｅｌ ｏｆ ｔｙｐｅ ２ ｄｉａｂｅｔｅｓ，Ｐｈｙｔｏｔｈｅｒａｐｙ Ｒｅｓｅａｒｃｈ，２００９年，Ｖｏｌ．２３， Ｎｏ．８，ｐ．１１８２－１１８５
Ｋｈｏｓｈｂａｔｅｎ Ｍ ｅｔ ａｌ，Ｇｒａｐｅ ｓｅｅｄ ｅｘｔｒａｃｔ ｔｏ ｉｍｐｒｏｖｅ ｌｉｖｅｒ ｆｕｎｃｔｉｏｎ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｎｏｎａｌｃｏｈｏｌｉｃ ｆａｔｔｙ ｌｉｖｅｒ ｃｈａｎｇｅ，Ｓａｕｄｉ Ｊｏｕｒｎａｌ ｏｆ Ｇａｓｔｒｏｅｎｔｅｒｏｌｏｇｙ，２０１０年 ７月，Ｖｏｌ．１６， Ｎｏ．３，ｐ．１９４－１９７，ｄｏｉ： １０．４１０３／１３１９－３７６７．６５１９７
Ｋｉｍ Ｈ ｅｔ ａｌ．，Ｄｉｅｔａｒｙ ｓｕｐｐｌｅｍｅｎｔａｔｉｏｎ ｏｆ ｃｈａｒｄｏｎｎａｙ ｇｒａｐｅ ｓｅｅｄ ｆｌｏｕｒ ｒｅｄｕｃｅｓ ｐｌａｓｍａ ｃｈｏｌｅｓｔｅｒｏｌ ｃｏｎｃｅｎｔｒａｔｉｏｎ， ｈｅｐａｔｉｃ ｓｔｅａｔｏｓｉｓ， ａｎｄ ａｂｄｏｍｉｎａｌ ｆａｔ ｃｏｎｔｅｎｔ ｉｎ ｈｉｇｈ－ｆａｔ ｄｉｅｔ－ｉｎｄｕｃｅｄ ｏｂｅｓｅ ｈａｍｓｔｅｒｓ，Ｊｏｕｒｎａｌ ｏｆ Ａｇｒｉｃｕｌｔｕｒａｌ ａｎｄ Ｆｏｏｄ Ｃｈｅｍｉｓｔｒｙ，２０１４年 ２月，Ｖｏｌ．６２， Ｎｏ．８，ｐ．１９１９－１９２５，ｄｏｉ： １０．１０２１／ｊｆ４０４８３２ｓ
メルクマニュアル 第１８版 日本語版，日経ＢＰ社，２００７年 ４月２５日，ｐ．１３５８－１３５９
メルクマニュアル 第１８版 日本語版，日経ＢＰ社，２００７年 ４月２５日，ｐ．１３８０
満尾 正，ハーブサプリメント，炎症と免疫，２００２年，第１０巻，第４号，ｐ．４３９－４４４

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021075551A (ja) * 2014-12-20 2021-05-20 ソノマシューティカルズ・エルエルシー 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物
JP7461901B2 (ja) 2014-12-20 2024-04-04 ソノマシューティカルズ・エルエルシー 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物

Also Published As

Publication number Publication date
US10894073B2 (en) 2021-01-19
EP3233101A1 (en) 2017-10-25
US11547736B2 (en) 2023-01-10
KR20170095271A (ko) 2017-08-22
US20170368128A1 (en) 2017-12-28
US20210236581A1 (en) 2021-08-05
JP7461901B2 (ja) 2024-04-04
NZ733322A (en) 2024-02-23
US10130671B2 (en) 2018-11-20
CA2971716A1 (en) 2016-06-23
IL252992A0 (en) 2017-08-31
KR20240059654A (ko) 2024-05-07
US20230293622A1 (en) 2023-09-21
IL252992B (en) 2022-02-01
JP2021075551A (ja) 2021-05-20
JP2017538758A (ja) 2017-12-28
AU2015364473A1 (en) 2017-07-13
US20190111099A1 (en) 2019-04-18
AU2015364473B2 (en) 2022-02-17
EP3233101A4 (en) 2018-08-01
WO2016100774A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
JP7461901B2 (ja) 非アルコール性脂肪肝疾患および他の使用のためのブドウ生成物
US9492424B2 (en) Muscle atrophy inhibitor
JP2008509213A (ja) 糖尿病患者のための食物製品
WO2012097064A1 (en) Nutritional compositions and methods for controlling blood glucose
WO2012097061A1 (en) Nutritional compositions and methods for improving skeletal muscle protein metabolism
CN119097620A (zh) 具有改善的生物利用度的中链甘油三酯制剂及其有关方法
US12539288B2 (en) Compositions and methods using at least one glycine or derivative thereof and/or at least one N-acetylcysteine or derivative thereof, and at least one thymol and/or carvacrol
JP2022169385A (ja) タモギタケ又はその処理物を有効成分として含む、脂質代謝改善剤
US20230364069A1 (en) Method for treating non-alcoholic steatohepatitis through co-administration of curcumin derivative and tgf-b receptor inhibitor
JP2009126830A (ja) 治療剤
KR102880529B1 (ko) 광어 효소 가수분해물을 이용한 근력 개선용 조성물
KR101629642B1 (ko) 피퍼롱구민을 유효성분으로 함유하는 지방간 예방용 식품 조성물, 지방간 치료용 약학 조성물, 지방간 치료용 동물 의약품 및 사료 조성물
JP2012062309A (ja) 筋肉増加用組成物
EP1221868A1 (en) Dietary supplement
KR20110076053A (ko) 스페니쉬 오레가노 추출물 또는 여름세이보리 추출물을 유효성분으로 함유하는 대사성 질환 예방 및 치료용 조성물
CN107106579A (zh) 兜甲蛋白减少的抑制/改善剂、谷氨酰胺转胺酶3激活剂和皮肤角质层角质化包膜的形成促进/结构增强剂
HK1237278A1 (en) Agent for promoting production of ceramide covalently bonded to horny cell

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200403

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20201006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210205

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210205

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210205

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210331

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210406

C272 Notice of ex officio correction

Free format text: JAPANESE INTERMEDIATE CODE: C272

Effective date: 20210406

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20210514

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20210518

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220412

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220607

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20220628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220927

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230110

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20230214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230512

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230721

R150 Certificate of patent or registration of utility model

Ref document number: 7319761

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150